Boston Partners Hologic Inc Transaction History

Boston Partners

$80.6 Billion
Q3 2024

A detailed history of Boston Partners transactions in Hologic Inc stock. As of the latest transaction made, Boston Partners holds 1,978,056 shares of HOLX stock, worth $153 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares

1,978,056

Holding current value

$153 Million

% of portfolio

0.2%

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$73.48 - $83.64 $145 Million - $165 Million	1,978,056 New	1,978,056 $161 Million
Q4 2022 Feb 07, 2023	SELL	$61.6 - $76.99 $3,819 - $4,773	-62 Reduced 0.06%	106,586 $7.97 Million
Q3 2022 Nov 09, 2022	SELL	$62.71 - $73.47 $353,872 - $414,591	-5,643 Reduced 5.03%	106,648 $6.93 Million
Q2 2022 Aug 10, 2022	SELL	$67.12 - $79.99 $13,960 - $16,637	-208 Reduced 0.18%	112,291 $7.78 Million
Q1 2022 May 10, 2022	SELL	$68.08 - $76.82 $345,574 - $389,938	-5,076 Reduced 4.32%	112,499 $8.64 Million
Q4 2021 Feb 04, 2022	SELL	$68.97 - $77.92 $15,380 - $17,376	-223 Reduced 0.19%	117,575 $9 Million
Q3 2021 Nov 05, 2021	SELL	$67.56 - $80.74 $181,533 - $216,948	-2,687 Reduced 2.23%	117,798 $8.69 Million
Q2 2021 Aug 12, 2021	BUY	$60.52 - $76.68 $7.29 Million - $9.24 Million	120,485 New	120,485 $8.04 Million

Others Institutions Holding HOLX

# of Institutions

776

Shares Held

220M

Call Options Held

874K

Put Options Held

371K

Vanguard Group Inc Valley Forge, PA

27M
Shares

$2.09 Billion
0.04% of portfolio
Black Rock Inc. New York, NY

23.1M
Shares

$1.79 Billion
0.04% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

22.1M
Shares

$1.71 Billion
1.09% of portfolio
Morgan Stanley New York, NY

10.9M
Shares

$843 Million
0.07% of portfolio
State Street Corp Boston, MA

10.4M
Shares

$806 Million
0.04% of portfolio

View Full List

About HOLOGIC INC

Ticker HOLX
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 249,652,992
Market Cap $19.3B
Description
Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The...

More about HOLX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Partners, based on Form 13F filings with the SEC.

News

Stay updated on Boston Partners with notifications on news.

Account